http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2168043-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d779448e816f508915ebf0e60c0ba809
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22
filingDate 1994-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4f46673d9e25cf2ef7bc22e48e025d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57ee6238e1280948c9c3f99daf60ecf
publicationDate 1995-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2168043-A1
titleOfInvention Method to inhibit restenosis
abstract A pharmaceutical composition to inhibit the development of intimal hyperplasia following vascular (angioplasty) is disclosed. The pharmaceutical composition contains green porphyrin and is administered to the subject concurrent with and following the angioplasty. No purposeful irradiation with light absorbed by the green porphyrin is required or employed with the composition.
priorityDate 1993-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66788048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12171167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449147235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150009356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449323691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410453302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148242732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433298372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426188030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3086257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428988782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67843295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447777546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16683900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5493302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11602

Total number of triples: 51.